Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study-Reference-Cited by-同舟云学术

Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study

Published:2023-10-11 Issue:6 Volume:10 Page:1637-1653
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Mease Philip J.^ORCID,Gladman Dafna D.^ORCID,Poddubnyy Denis,Chakravarty Soumya D.^ORCID,Shawi May^ORCID,Kollmeier Alexa P.,Xu Xie L.,Xu Stephen,Deodhar Atul^ORCID,Baraliakos Xenofon^ORCID

Funder

Janssen Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s40744-023-00592-8.pdf

Reference50 articles.

1. Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14:363–71.

2. Gladman DD. Axial disease in psoriatic arthritis. Curr Rheumatol Rep. 2007;9:455–60.

3. Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851–64.